Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126531662 | 12653166 | 2 | F | 20160809 | 20160815 | 20160822 | EXP | CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-52377CN | BOEHRINGER INGELHEIM | 65.00 | YR | F | Y | 0.00000 | 20160822 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126531662 | 12653166 | 1 | PS | MICARDIS Plus | HYDROCHLOROTHIAZIDETELMISARTAN | 1 | Oral | U | 20850 | TABLET | |||||||||
| 126531662 | 12653166 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | FORMULATION: SOLUTION INTRAVENOUS | U | 0 | |||||||||
| 126531662 | 12653166 | 3 | SS | FILGRASTIM | FILGRASTIM | 1 | Unknown | U | 0 | ||||||||||
| 126531662 | 12653166 | 4 | SS | PERTUZUMAB | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | 40 MG | U | 0 | 840 | MG | Q3W | ||||||
| 126531662 | 12653166 | 5 | SS | PERTUZUMAB | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | 20 MG | U | 0 | 420 | MG | Q3W | ||||||
| 126531662 | 12653166 | 6 | C | 5-FU | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 126531662 | 12653166 | 7 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | |||||||||||
| 126531662 | 12653166 | 8 | C | EPIRUBICIN | EPIRUBICIN | 1 | Intravenous (not otherwise specified) | FORMULATION: SOLUTION INTRAVENOUS | 0 | ||||||||||
| 126531662 | 12653166 | 9 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | TABLET | ||||||||||
| 126531662 | 12653166 | 10 | C | TELMISARTAN. | TELMISARTAN | 1 | Unknown | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126531662 | 12653166 | 1 | Hypertension |
| 126531662 | 12653166 | 2 | Product used for unknown indication |
| 126531662 | 12653166 | 3 | Prophylaxis |
| 126531662 | 12653166 | 4 | Breast cancer |
| 126531662 | 12653166 | 6 | Product used for unknown indication |
| 126531662 | 12653166 | 7 | Product used for unknown indication |
| 126531662 | 12653166 | 8 | Product used for unknown indication |
| 126531662 | 12653166 | 9 | Product used for unknown indication |
| 126531662 | 12653166 | 10 | Blood pressure measurement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126531662 | 12653166 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126531662 | 12653166 | Blood potassium decreased | |
| 126531662 | 12653166 | Diarrhoea | |
| 126531662 | 12653166 | Dizziness | |
| 126531662 | 12653166 | Hypotension | |
| 126531662 | 12653166 | Influenza like illness | |
| 126531662 | 12653166 | Unresponsive to stimuli | |
| 126531662 | 12653166 | Vomiting | |
| 126531662 | 12653166 | White blood cell count abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |